Great Tree Pharmacy Co., Ltd. (TPEX:6469)
84.00
-1.20 (-1.41%)
At close: Mar 6, 2026
Great Tree Pharmacy Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 18,896 | 17,274 | 16,144 | 14,565 | 11,281 | Upgrade
|
| Revenue Growth (YoY) | 9.39% | 7.00% | 10.84% | 29.11% | 30.55% | Upgrade
|
| Cost of Revenue | 13,479 | 12,432 | 11,658 | 10,554 | 8,338 | Upgrade
|
| Gross Profit | 5,417 | 4,843 | 4,486 | 4,011 | 2,943 | Upgrade
|
| Selling, General & Admin | 4,727 | 4,041 | 3,680 | 3,149 | 2,451 | Upgrade
|
| Operating Expenses | 4,727 | 4,041 | 3,680 | 3,149 | 2,451 | Upgrade
|
| Operating Income | 689.33 | 801.19 | 805.56 | 861.87 | 492.31 | Upgrade
|
| Interest Expense | -85.83 | -58.9 | -57.5 | -45.85 | -35.13 | Upgrade
|
| Interest & Investment Income | 38.56 | 13.27 | 15.88 | 4.32 | 0.74 | Upgrade
|
| Earnings From Equity Investments | -1.16 | -0.79 | -0.93 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | 3.73 | 1.53 | 12.54 | -1.86 | Upgrade
|
| Other Non Operating Income (Expenses) | 103.08 | 83.46 | 76.01 | 48.25 | 50.91 | Upgrade
|
| EBT Excluding Unusual Items | 743.99 | 841.95 | 840.55 | 881.14 | 506.97 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 4.39 | -0.72 | -0.43 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 0.42 | 0.5 | 1.12 | 0.1 | Upgrade
|
| Other Unusual Items | - | - | 1.49 | 0.5 | 2.6 | Upgrade
|
| Pretax Income | 743.99 | 846.77 | 841.82 | 882.33 | 509.67 | Upgrade
|
| Income Tax Expense | 162.49 | 166.8 | 175.34 | 181.83 | 101.91 | Upgrade
|
| Earnings From Continuing Operations | 581.5 | 679.96 | 666.48 | 700.5 | 407.76 | Upgrade
|
| Minority Interest in Earnings | 18.92 | 0.8 | -0.44 | -0.43 | -0.34 | Upgrade
|
| Net Income | 600.42 | 680.77 | 666.05 | 700.07 | 407.42 | Upgrade
|
| Net Income to Common | 600.42 | 680.77 | 666.05 | 700.07 | 407.42 | Upgrade
|
| Net Income Growth | -11.80% | 2.21% | -4.86% | 71.83% | 109.67% | Upgrade
|
| Shares Outstanding (Basic) | 150 | 149 | 147 | 145 | 143 | Upgrade
|
| Shares Outstanding (Diluted) | 154 | 154 | 155 | 150 | 148 | Upgrade
|
| Shares Change (YoY) | 0.08% | -0.33% | 3.19% | 1.51% | 3.36% | Upgrade
|
| EPS (Basic) | 4.01 | 4.57 | 4.54 | 4.83 | 2.86 | Upgrade
|
| EPS (Diluted) | 3.89 | 4.49 | 4.40 | 4.70 | 2.76 | Upgrade
|
| EPS Growth | -13.36% | 1.96% | -6.35% | 70.41% | 100.79% | Upgrade
|
| Free Cash Flow | 839.12 | 779.64 | 594.08 | 924.01 | 829.21 | Upgrade
|
| Free Cash Flow Per Share | 5.44 | 5.05 | 3.84 | 6.16 | 5.61 | Upgrade
|
| Dividend Per Share | - | 2.918 | 2.724 | 2.895 | 1.260 | Upgrade
|
| Dividend Growth | - | 7.15% | -5.93% | 129.89% | 233.29% | Upgrade
|
| Gross Margin | 28.67% | 28.03% | 27.79% | 27.54% | 26.09% | Upgrade
|
| Operating Margin | 3.65% | 4.64% | 4.99% | 5.92% | 4.36% | Upgrade
|
| Profit Margin | 3.18% | 3.94% | 4.13% | 4.81% | 3.61% | Upgrade
|
| Free Cash Flow Margin | 4.44% | 4.51% | 3.68% | 6.34% | 7.35% | Upgrade
|
| EBITDA | 1,571 | 1,069 | 1,046 | 1,071 | 663.11 | Upgrade
|
| EBITDA Margin | 8.31% | 6.19% | 6.48% | 7.35% | 5.88% | Upgrade
|
| D&A For EBITDA | 881.93 | 268.1 | 240.04 | 208.92 | 170.8 | Upgrade
|
| EBIT | 689.33 | 801.19 | 805.56 | 861.87 | 492.31 | Upgrade
|
| EBIT Margin | 3.65% | 4.64% | 4.99% | 5.92% | 4.36% | Upgrade
|
| Effective Tax Rate | 21.84% | 19.70% | 20.83% | 20.61% | 19.99% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.